During the past decade, Centro de Dermatología de Monterrey conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Dermatología de Monterrey" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Dermatología de Monterrey" are "Psoriasis" (3 trials), "Dermatitis, Atopic" (2 trials), "Eczema" (2 trials), "Atopic Dermatitis" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Centro de Dermatología de Monterrey" in a lesser frequency.

Most popular intervention types in "Centro de Dermatología de Monterrey" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CP-690,550" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "High Strength IDP-108" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Dermatología de Monterrey" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Dermatología de Monterrey". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro de Dermatología de Monterrey, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Dermatología de Monterrey, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".